HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 617 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,046 | +3610.3% | 43,613 | +3209.0% | 0.06% | +5700.0% |
| Q2 2023 | $136 | -96.8% | 1,318 | -96.6% | 0.00% | -98.0% |
| Q1 2023 | $4,279 | +1947.4% | 39,203 | +2036.4% | 0.05% | +1566.7% |
| Q4 2022 | $209 | -100.0% | 1,835 | -90.7% | 0.00% | -80.0% |
| Q3 2022 | $1,217,000 | -51.2% | 19,670 | -37.1% | 0.02% | -44.4% |
| Q2 2022 | $2,492,000 | +273.1% | 31,249 | +392.4% | 0.03% | +440.0% |
| Q1 2022 | $668,000 | -67.4% | 6,346 | -66.6% | 0.01% | -54.5% |
| Q4 2021 | $2,047,000 | -44.8% | 18,998 | -43.8% | 0.01% | -35.3% |
| Q3 2021 | $3,706,000 | +30.3% | 33,828 | +11.4% | 0.02% | +30.8% |
| Q2 2021 | $2,844,000 | +31.6% | 30,368 | +29.4% | 0.01% | +18.2% |
| Q1 2021 | $2,161,000 | -54.8% | 23,474 | -64.1% | 0.01% | -57.7% |
| Q4 2020 | $4,780,000 | +387.3% | 65,345 | +417.6% | 0.03% | +333.3% |
| Q3 2020 | $981,000 | +25.1% | 12,624 | -10.5% | 0.01% | -14.3% |
| Q2 2020 | $784,000 | +122.7% | 14,106 | +18.9% | 0.01% | +133.3% |
| Q1 2020 | $352,000 | +9.0% | 11,867 | +33.0% | 0.00% | 0.0% |
| Q4 2019 | $323,000 | -25.9% | 8,925 | -44.3% | 0.00% | -25.0% |
| Q3 2019 | $436,000 | -27.5% | 16,030 | -35.8% | 0.00% | 0.0% |
| Q2 2019 | $601,000 | – | 24,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |